Product Information

CHEST CONGEST RLF 400 MG TAB is a generic product labeled by Rugby Laboratories, priced at $0.0653 per EA under NDC 00536131108. Its NADAC has been published 275 times since May 19, 2021.

CHEST CONGEST RLF 400 MG TAB

Guaifenesin
$0.0653per EA
OTC

Strength

400 mg/1

Manufacturer

Rugby Laboratories

NDC

00536131108

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GUAIFENESIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

9/1/2020

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions

Price Statistics

The NADAC for CHEST CONGEST RLF 400 MG TAB has been published 275 times since May 19, 2021, and over the history we have for it it has declined 6.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0653 per EA
All-time high$0.0744 (Nov 13, 2024)
All-time low$0.0560 (Apr 19, 2023)
52-week high$0.0683
52-week low$0.0653
Median price$0.0677
Average price$0.0672
Largest weekly change+13.5% (May 17, 2023)
Weeks tracked275
Tracking sinceMay 19, 2021

Price History

1W

-2.1%

1M

-2.1%

3M

-2.9%

6M

-1.3%

1Y

-3.7%

3Y

-2.4%

5Y

-4.4%

All

-6.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CHEST CONGEST RLF 400 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for CHEST CONGEST RLF 400 MG TAB, manufactured by Rugby Laboratories, is $0.0653 per EA (NDC 00536131108), effective Aug 19, 2026.

How has the price of CHEST CONGEST RLF 400 MG TAB changed over time?

Over the history we have for it, the NADAC for CHEST CONGEST RLF 400 MG TAB has declined 6.3%. It has been tracked across 275 weekly CMS publications since May 19, 2021.

What are the highest and lowest recorded NADAC prices for CHEST CONGEST RLF 400 MG TAB?

Since May 19, 2021, the NADAC for CHEST CONGEST RLF 400 MG TAB has ranged from a low of $0.0560 (Apr 19, 2023) to a high of $0.0744 (Nov 13, 2024), with a median of $0.0677 per EA.

Are there cheaper alternatives to CHEST CONGEST RLF 400 MG TAB?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHEST CONGEST RLF 400 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures CHEST CONGEST RLF 400 MG TAB?

CHEST CONGEST RLF 400 MG TAB (NDC 00536131108) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.